Legal Representation
Attorney
Matthew A. Homyk
USPTO Deadlines
Next Deadline
225 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20200901)
Due Date
September 01, 2026
Grace Period Ends
March 01, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
18 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 1, 2025 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | Loading... |
| Sep 1, 2020 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jun 16, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 16, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 27, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 11, 2020 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Apr 30, 2020 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 30, 2020 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Apr 30, 2020 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Apr 30, 2020 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Apr 30, 2020 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Apr 29, 2020 | GPRN | O | NOTIFICATION OF PRIORITY ACTION E-MAILED | Loading... |
| Apr 29, 2020 | GPRA | F | PRIORITY ACTION E-MAILED | Loading... |
| Apr 29, 2020 | CPRA | R | PRIORITY ACTION WRITTEN | Loading... |
| Apr 27, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 11, 2020 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Feb 10, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 10, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of neurological, renal, hematopoietic, thyroid, and ophthalmic diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Anti-inflammatory pharmaceutical preparations; Cardiovascular pharmaceuticals; anti-microbial pharmaceutical preparations; anti-neoplastic pharmaceutical preparations; immunomodulatory pharmaceutical preparations; hematopoietic pharmaceutical preparations; Pharmaceutical preparations, namely, anticoagulants; pharmaceutical preparations, namely, thrombolytic agents; antiplatelets, namely, platelet agglutination inhibitors and platelet aggregation inhibitors; Estrogen preparations; pharmaceutical preparations, namely, progestin; Androgen preparations; Antithyroid pharmaceutical preparations used to treat hyperthyroidism; Pharmaceutical preparations for treating diabetes; pharmaceutical preparations, namely, histamine H2 receptor antagonists and proton pump antagonists; anti-emetic pharmaceutical preparations; anti-convulsant pharmaceutical preparations; pharmaceutical preparations for the treatment of asthma; anti-diabetic pharmaceuticals
First Use Anywhere:
Jan 29, 2020
First Use in Commerce:
Jan 29, 2020
Class 040
Custom manufacture of pharmaceuticals for others; providing technical information in the field of pharmaceutical manufacturing
First Use Anywhere:
Jan 29, 2020
First Use in Commerce:
Jan 29, 2020
Class 042
Development of pharmaceutical preparations and medicines
First Use Anywhere:
Jan 29, 2020
First Use in Commerce:
Jan 29, 2020
Additional Information
Design Mark
The mark consists of four rounded bars converging at the center at ninety-degree angles, each separated perpendicularly by circles in the spaces between the bars.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005
040
042